| A/E | Accident and emergency |
| ACEI | Angiotensin converting enzyme inhibitor |
| ADE | Adverse drug event |
| ADR | Adverse drug reaction |
| AF | Atrial fibrillation |
| AT | Angiotensin |
| CCB | Calcium channel blocker |
| CHF | Congestive heart failure |
| CVDs | Cardiovascular diseases |
| DM | Diabetes mellitus |
| DMT2 | Diabetes mellitus type 2 |
| GP | General practitioner |
| GTN | Glyceryl trinitrate |
| HTN | Hypertension |
| ICD-10 | International Classification of Diseases |
| LVD | Left ventricular disease |
| IHD | Ischaemic heart disease |
| ME | Medication error |
| MI | Myocardial infarction |
| MRH | Medicine-related hospitalisation |
| MRP | Medicine-related problem |
| N | Number |
| NCDs | Non-communicable diseases |
| NICE | National Institute of Health and Care Excellence |
| NPSA | National Patient Safety Agency |
| NSTEMI | Non-ST elevated myocardial infarction |
| OP | Operations |
| OR | Odds ratio |
| PCNE | Pharmaceutical Care Network Europe |
| PPI | Proton pump inhibitor |
| SA | Saudi Arabia |
| SVD | Supraventricular disease |
| TE | Treatment effectiveness |
| WHO | World Health Organisation |